ArticleNeuroinformatics2026
Cross-Platform Neurotransmitter & Alias Ambiguity for OA-AL2b1 and OA-AL2b2 Neurons in Drosophila melanogaster.
Article in Neuroinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate neuron identification is necessary for reproducible connectomics. While examining historically described octopaminergic neurons of the Drosophila melanogaster optic lobe, I found that most octopaminergic (OA) neurons of interest remained searchable under their original names across commonly used resources. However, two neurons did not behave the same way. OA- AL2b1, which was linked to the alias LoVCLo3, and OA-AL2b2, which was linked to the alias MeVCMe1. This created a selective nomenclature problem. OA-AL2b1 was especially notable because it remained octopaminergic in the queried resources, yet its historical OA-based name was not consistently preserved as the searchable or visible label. OA-AL2b2 showed a different pattern; in current connectomic tools, it was labeled cholinergic, whereas in other databases, it still remained under octopaminergic groupings. Importantly, Busch et al. originally noted that OA-AL2b2 was not confirmed to be octopamine immunoreactive. An additional layer of ambiguity arose because neuPrint displayed a predicted neurotransmitter (NT) field, whereas Neuroglancer displayed consensus NT, both showing Acetylcholine as its NT. Together, these observations show how small inconsistencies in nomenclature and annotation can create major practical problems in neuron retrieval, interpretation, and cross-platform reproducibility. Although this report focuses on two neurons in Drosophila, the same problem can arise more broadly whenever historical names, database aliases, and current annotation systems are not interlinked.
Indexed as
Identifiers
42043632What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.